Rennova Health Inc (RNVA)
0.0001
USD |
OTCM |
May 01, 14:41
Rennova Health Cash from Operations (TTM): -4.389M for Sept. 30, 2022
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
September 30, 2022 | -4.389M |
June 30, 2022 | -6.390M |
March 31, 2022 | -8.951M |
December 31, 2021 | -8.913M |
September 30, 2021 | -9.096M |
June 30, 2021 | -11.54M |
March 31, 2021 | -15.55M |
December 31, 2020 | -16.93M |
September 30, 2020 | -12.68M |
June 30, 2020 | -17.23M |
March 31, 2020 | -15.14M |
December 31, 2019 | -13.53M |
September 30, 2019 | -14.93M |
June 30, 2019 | -7.348M |
March 31, 2019 | -6.223M |
December 31, 2018 | -7.679M |
September 30, 2018 | -13.04M |
June 30, 2018 | -14.86M |
March 31, 2018 | -14.10M |
December 31, 2017 | -17.71M |
September 30, 2017 | -14.62M |
June 30, 2017 | -16.58M |
March 31, 2017 | -18.82M |
December 31, 2016 | -19.86M |
September 30, 2016 | -17.95M |
Date | Value |
---|---|
June 30, 2016 | -14.23M |
March 31, 2016 | -10.30M |
September 30, 2015 | -4.251M |
June 30, 2015 | -4.254M |
March 31, 2015 | -3.565M |
December 31, 2014 | -3.365M |
September 30, 2014 | -2.843M |
June 30, 2014 | -2.553M |
March 31, 2014 | -2.431M |
December 31, 2013 | -2.661M |
September 30, 2013 | -3.367M |
June 30, 2013 | -4.12M |
March 31, 2013 | -3.838M |
December 31, 2012 | -3.668M |
September 30, 2012 | -3.172M |
June 30, 2012 | -2.402M |
March 31, 2012 | -3.108M |
December 31, 2011 | -2.661M |
September 30, 2011 | 1.337M |
June 30, 2011 | -0.453M |
March 31, 2011 | -0.074M |
December 31, 2010 | -0.746M |
September 30, 2010 | -4.498M |
June 30, 2010 | -3.711M |
March 31, 2010 | -4.887M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-17.23M
Minimum
Jun 2020
-4.389M
Maximum
Sep 2022
-11.61M
Average
-12.11M
Median
Cash from Operations (TTM) Benchmarks
CEL-SCI Corp | -23.07M |
AIM ImmunoTech Inc | -21.27M |
IGC Pharma Inc | -6.19M |
NovaBay Pharmaceuticals Inc | -4.131M |
Protalix BioTherapeutics Inc | -1.318M |